Dermatologic Manifestations of Zika Virus (DMZV)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03229421 |
Recruitment Status :
Withdrawn
(Unable to enroll eligible participants)
First Posted : July 25, 2017
Last Update Posted : February 4, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Zika Virus Symptoms and the Associated Exanthema | Other: Survey |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Survey of Symptoms and Dermatologic Characterization Associated With Zika Virus |
Actual Study Start Date : | July 6, 2017 |
Actual Primary Completion Date : | December 31, 2018 |
Actual Study Completion Date : | December 31, 2018 |

- Other: Survey
18 question symptom assessment tool including non-identifying demographic information questions.
- Number of days with specific symptoms [ Time Frame: 20 minutes ]Number of days reported experiencing specific symptoms due to Zika Virus infection and and associated characteristics such as location and intensity
- Frequency measures of initial clinical presentations [ Time Frame: 20 minutes ]Frequency of reported symptoms at initial clinical presentation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Adults aged 18 years and older presenting with febrile illness and rash
Exclusion Criteria:
- Patients aged 17 years or younger

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03229421
Dominican Republic | |
Pontificia Universidad Catolica Madre y Maestra, Departamento de Medicina | |
Santo Domingo, Illinois, Dominican Republic |
Principal Investigator: | Roopal V. Kundu, MD | Northwestern University |
Responsible Party: | Roopal Kundu, Principal Investigator, Northwestern University |
ClinicalTrials.gov Identifier: | NCT03229421 |
Other Study ID Numbers: |
STU00205325 |
First Posted: | July 25, 2017 Key Record Dates |
Last Update Posted: | February 4, 2019 |
Last Verified: | January 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Zika Virus |
Zika Virus Infection Exanthema Virus Diseases Infections Arbovirus Infections |
Vector Borne Diseases Flavivirus Infections Flaviviridae Infections RNA Virus Infections Skin Diseases |